Orlando leads MeTree software recommended by President’s Cancer Panel
Dr. Lori Orlando leads the team behind MeTree and studies decision modeling and implementation science as it relates to identifying and managing individuals in clinical settings at increased risk for medical conditions.
Pearls from 2/08/2022 LEADS
The February 8, 2022, session of Duke Medicine LEADS featured Bryan C. Batch, MD, MHS, Nia S.
CAGPM’s MeTree software recommended by President’s Cancer Panel
More effective and equitable implementation of cancer screening represents a significant opportunity for the National Cancer Program, with the potential to reduce the burden of cancer, according to a report released February 2, 2022, by the President’s Cancer Panel. The Panel’s report, Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access, presents goals and recommendations to optimize cancer screening informed by a series of meetings conducted 2020-2021.
Pearls from 2/02/2022 LEADS
The February 2, 2022, session of Duke Medicine LEADS featured Brian Sullivan, MD, MHS "Colorectal Cancer Screening."
Pearls
Gupta Joins DMPI as First Duke Science & Technology Award Recipient
Dr. Rana Gupta, PhD, a preeminent investigator in the field of adipose biology, will join the Duke Molecular Physiology Institute (DMPI) faculty with an anticipated start date of summer 2022.